Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESTORE: Hydroxychloroquine in recurrent pericarditis
NCT05737680Phase 3Unknown
- Sponsor
- Hippocration General Hospital
- Start
- Feb 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in pericarditis, sponsored by Hippocration General Hospital. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
pericarditis
Beyond the preview
Go deeper on NCT05737680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05737680.